Doptelet is a medicine used to prevent excessive bleeding in adults with thrombocytopenia due to long-standing liver disease. Patients with thrombocytopenia have reduced number of platelets (components in the blood that help it to clot), which can cause excessive bleeding. The medicine is for use in patients having an invasive procedure (a medical procedure that involves cutting into or puncturing the skin or inserting instruments into the body). Doptelet contains the active substance avatrombopag.
Therapeutic Indication
### Therapeutic indication Doptelet is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure. Doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).
Therapeutic Area (MeSH)
N/AATC Code
B02BX
ATC Item
其它系统止血药
Pharmacotherapeutic Group
Antihemorrhagics
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| avatrombopag maleate | N/A | 阿伐曲泊帕 |
EMA Name
Doptelet
Medicine Name
Doptelet
Aliases
N/ANo risk management plan link.
